Theodore G. Liou

Theodore G. Liou, MD, is a Professor of Internal Medicine and Adjunct Associate Professor of Pediatrics at the University of Utah School of Medicine, serving as Director of the Adult Cystic Fibrosis Center at University of Utah Hospital. With over seventeen years of leadership, he directs an award-winning CF care team and maintains triple board certification in Internal Medicine, Pulmonary Disease, and Critical Care Medicine.

His educational background includes:

• B.A. in Biochemistry from University of California - Berkeley
• M.D. from George Washington University
• Internal Medicine internship/residency at Presbyterian-University Hospital
• Pulmonary/Critical Care fellowship at University of Utah School of Medicine

Dr. Liou's research spans cystic fibrosis, sepsis, ARDS, airway inflammation, pneumonia, airway ecology, and antibiotic discovery, yielding landmark publications in JAMA, NEJM, and The Lancet. His work has established foundational insights in CF lung disease and transplantation outcomes.

Analysis of his 2017-2023 publications reveals consistent focus on CF therapeutics (mRNA therapy, CFTR modulators), predictive modeling of survival/lung function, and airway microbiome dynamics, alongside critical care applications in sepsis and environmental health impacts. This body of work demonstrates rigorous clinical translation with direct patient care implications.

No individual scientific awards are specified in available records, though his CF team has received institutional recognition. Details regarding student advising and grant funding remain undisclosed in source materials.

Dr. Liou leads the Adult CF Center as both clinical director and research innovator, integrating patient-centered care with cutting-edge clinical trials. His team's multidisciplinary approach addresses complex CF management while advancing therapeutic discovery through partnerships with industry leaders like Genentech and Merck.